J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Analyst Forecasts For Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Are Surging Higher
Sangamo Stock Climbs 12% Post-market on FDA Update for ST-503
Sangamo Therapeutics Gets FDA Clearance for Investigational NDA for Pain Treatment
Sangamo Therapeutics Gets FDA Clearance Of IND Application For ST-503 For Treatment Of Idiopathic Small Fiber Neuropathy
Express News | Sangamo Therapeutics Inc - to Initiate Phase 1/2 Study for St-503 in Mid-2025
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Exactly : I watch this since ww2